Forian Inc.

Forian provides data science-driven information and analytics solutions to the life sciences, healthcare, and financial services industries. The company offers data management capabilities and proprietary enriched information and analytics solutions designed to optimize and measure operational, clinical, and financial performance for its customers. Its subscription and services-based solutions serve the life sciences, pharmaceutical services, healthcare payer and provider, and financial services industries. Forian was founded on October 15, 2020, as a wholly owned subsidiary of Medical Outcomes Research Analytics, LLC ("MOR"), which was founded on May 6, 2019. On October 16, 2020, Forian entered into an agreement with Helix Technologies, Inc. ("Helix") and MOR, resulting in Helix becoming a wholly owned subsidiary of Forian. On March 2, 2021, Forian acquired MOR. Following these transactions, Forian became the parent company of both Helix and MOR. On March 3, 2021, Forian's common stock, par value $0.001 per share, began trading on the Nasdaq Capital Market under the ticker symbol "FORA." On February 10, 2023, Helix sold 100% of the outstanding capital stock of its wholly owned subsidiary, Bio-Tech Medical Software, Inc. ("BioTrack"), to BT Assets Group Inc., a wholly owned subsidiary of Alleaves Inc. On October 31, 2024, Forian acquired 100% of the outstanding membership interests of Kyber Data Science LLC from Cowen Inc. and IMcK Holdings LLC.